Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 GeneticVariation disease BEFREE Compared with the control group, the SCL-90 test scores of pregnant women in the intervention group were significantly lower in the following five factors: somatization, interpersonal sensitivity, depression, anxiety and fear (p<0.05). 31714444 2020
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 GeneticVariation disease BEFREE Compared with the control group, the SCL-90 test scores of pregnant women in the intervention group were significantly lower in the following five factors: somatization, interpersonal sensitivity, depression, anxiety and fear (p<0.05). 31714444 2020
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 GeneticVariation disease BEFREE Compared with the control group, the SCL-90 test scores of pregnant women in the intervention group were significantly lower in the following five factors: somatization, interpersonal sensitivity, depression, anxiety and fear (p<0.05). 31714444 2020
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 GeneticVariation disease BEFREE The effect size statistics identified somatization in both BSI-18 and SCL-90-R as the most prevalent and intense symptom of psychological distress. 30017779 2019
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 GeneticVariation disease BEFREE The effect size statistics identified somatization in both BSI-18 and SCL-90-R as the most prevalent and intense symptom of psychological distress. 30017779 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 Biomarker disease BEFREE The comparison of the patient and control groups based on SCL-90-R findings demonstrated that the patient group scores in somatization, anxiety (p = 0.000), depression (p = 0.003), anger (p = 0.02), interpersonal sensitivity (p = 0.006), phobia (p = 0.001), paranoid thoughts (p = 0.012), psychosis (p = 0.031) subscales and additional subscale (p = 0.014) and general symptom index (p = 0.001) scores were higher. 30472336 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 Biomarker disease BEFREE Symptoms of anxiety and depression were assessed by the Hopkins Symptom Checklist-25 (HSCL-25), somatization was assessed by the Somatization Subscale of the Symptom-Checklist-90 (SCL-90), and the number of witnessed and experienced trauma was assessed by the Posttraumatic Diagnostic Scale (PDS/HTQ). 31088419 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 GeneticVariation disease BEFREE The effect size statistics identified somatization in both BSI-18 and SCL-90-R as the most prevalent and intense symptom of psychological distress. 30017779 2019
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 Biomarker disease BEFREE Symptoms of anxiety and depression were assessed by the Hopkins Symptom Checklist-25 (HSCL-25), somatization was assessed by the Somatization Subscale of the Symptom-Checklist-90 (SCL-90), and the number of witnessed and experienced trauma was assessed by the Posttraumatic Diagnostic Scale (PDS/HTQ). 31088419 2019
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 Biomarker disease BEFREE The comparison of the patient and control groups based on SCL-90-R findings demonstrated that the patient group scores in somatization, anxiety (p = 0.000), depression (p = 0.003), anger (p = 0.02), interpersonal sensitivity (p = 0.006), phobia (p = 0.001), paranoid thoughts (p = 0.012), psychosis (p = 0.031) subscales and additional subscale (p = 0.014) and general symptom index (p = 0.001) scores were higher. 30472336 2019
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 Biomarker disease BEFREE Symptoms of anxiety and depression were assessed by the Hopkins Symptom Checklist-25 (HSCL-25), somatization was assessed by the Somatization Subscale of the Symptom-Checklist-90 (SCL-90), and the number of witnessed and experienced trauma was assessed by the Posttraumatic Diagnostic Scale (PDS/HTQ). 31088419 2019
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 Biomarker disease BEFREE The comparison of the patient and control groups based on SCL-90-R findings demonstrated that the patient group scores in somatization, anxiety (p = 0.000), depression (p = 0.003), anger (p = 0.02), interpersonal sensitivity (p = 0.006), phobia (p = 0.001), paranoid thoughts (p = 0.012), psychosis (p = 0.031) subscales and additional subscale (p = 0.014) and general symptom index (p = 0.001) scores were higher. 30472336 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 GeneticVariation disease BEFREE Among the various SCL-90-R or SCL-28 subscales we identified from the clinimetric analysis that the somatization, anxiety, phobic anxiety, psychoticism, and neurasthenia (apathy), as well as the SCL-90-R GSI, were the most impaired psychiatric syndromes reaching a clinically significant effect size above 0.80, whereas the total SCL-28 GSI obtained an effect size of just 0.80. 29100973 2018
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 GeneticVariation disease BEFREE There was no clinically significant difference (effect size = <0.50) in the SCL-90-R total score between the pre-surgical and the healthy controls samples, although pre-surgical patients had lower mean scores compared to the healthy controls in all subscales except somatization (effect size = -0.22). 29022751 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 GeneticVariation disease BEFREE Among the various SCL-90-R or SCL-28 subscales we identified from the clinimetric analysis that the somatization, anxiety, phobic anxiety, psychoticism, and neurasthenia (apathy), as well as the SCL-90-R GSI, were the most impaired psychiatric syndromes reaching a clinically significant effect size above 0.80, whereas the total SCL-28 GSI obtained an effect size of just 0.80. 29100973 2018
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 GeneticVariation disease BEFREE Among the various SCL-90-R or SCL-28 subscales we identified from the clinimetric analysis that the somatization, anxiety, phobic anxiety, psychoticism, and neurasthenia (apathy), as well as the SCL-90-R GSI, were the most impaired psychiatric syndromes reaching a clinically significant effect size above 0.80, whereas the total SCL-28 GSI obtained an effect size of just 0.80. 29100973 2018
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.100 Biomarker disease BEFREE Compared with control women, women with PCOS reported significantly higher scores on SCL-90-R scales of somatization, anxiety, hostility, psychoticism, overall psychological distress and a number of symptoms. 28385114 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 GeneticVariation disease BEFREE There was no clinically significant difference (effect size = <0.50) in the SCL-90-R total score between the pre-surgical and the healthy controls samples, although pre-surgical patients had lower mean scores compared to the healthy controls in all subscales except somatization (effect size = -0.22). 29022751 2018
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 GeneticVariation disease BEFREE There was no clinically significant difference (effect size = <0.50) in the SCL-90-R total score between the pre-surgical and the healthy controls samples, although pre-surgical patients had lower mean scores compared to the healthy controls in all subscales except somatization (effect size = -0.22). 29022751 2018
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 Biomarker disease BEFREE Compared with control women, women with PCOS reported significantly higher scores on SCL-90-R scales of somatization, anxiety, hostility, psychoticism, overall psychological distress and a number of symptoms. 28385114 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 Biomarker disease BEFREE Compared with control women, women with PCOS reported significantly higher scores on SCL-90-R scales of somatization, anxiety, hostility, psychoticism, overall psychological distress and a number of symptoms. 28385114 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 GeneticVariation disease BEFREE Compared with Chinese normative data taken from literature, patients with PKD exhibited significantly higher (worse) scores across all SCL-90-R subscales (somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism; P= 0.000 for all) and significantly lower (worse) scores of five domains in WHOQoL-100 (physical domain, psychological domain, independence domain, social relationship domain, and general quality of life; P= 0.000 for all). 28836553 2017
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 GeneticVariation disease BEFREE Compared with Chinese normative data taken from literature, patients with PKD exhibited significantly higher (worse) scores across all SCL-90-R subscales (somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism; P= 0.000 for all) and significantly lower (worse) scores of five domains in WHOQoL-100 (physical domain, psychological domain, independence domain, social relationship domain, and general quality of life; P= 0.000 for all). 28836553 2017
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.100 Biomarker disease BEFREE Results showed significant positive differences between groups in the first trimester regarding the Somatization subscale of the SCL-90-R (p < .05). 28846691 2017
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.100 Biomarker disease BEFREE Questionnaires which included State-Trait Anxiety Inventory (STAI), Center for Epidemiological studies-Depression Scale (CED-S), and Symptom Checklist-90-Revised (SCL-90-R) were used to identify anxiety and somatization. 29209375 2017